Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
about
Animal models of hemophiliaSuppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cellsTransient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy.Immune responses to human factor IX in haemophilia B mice of different genetic backgrounds are distinct and modified by TLR4.Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery.Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 gene.Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype.Downregulation of CD40 signal and induction of TGF-β by phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIIIInhibitors - genetic and environmental factors.Gene therapy for immune tolerance induction in hemophilia with inhibitors.Factor VIII inhibitors: Advances in basic and translational science.Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A.A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.Dexamethasone promotes durable factor VIII -specific tolerance in hemophilia A mice via thymic mechanisms.
P2860
Q27012571-EA24532D-25C9-4CD2-9D68-C63CC5EF4F6CQ34137024-EBF32B25-00CA-4610-849B-11E65A492F27Q34289040-DAC82D0F-220E-4598-A527-4F3B79755EA6Q35023274-50459450-0594-49F6-BECF-D6CC0CB0B8EBQ35184180-7113CFB2-4893-491C-BB48-10693A2DB95AQ36586264-786D9F5B-550B-4324-976C-E4502AAF3787Q36873312-6AAEB72A-E8B7-4311-82FE-394061E15946Q37718280-150FB86E-969F-44B3-8865-181771E677A1Q38206856-78AA73C0-E5CD-4D0F-9A8F-0FE1378F9B22Q38803022-02B00F9B-9D24-47BC-B585-9878923E55DFQ39266287-0C03D6DE-F855-4809-8734-F4D43FA4122DQ41721581-6011957A-3A74-4C68-BDC6-83CD8EBB9900Q45868319-9509426D-835E-4BEE-951E-02A620D48BBDQ50622853-B3E8A665-0B44-4BFC-8080-D7C0193088EAQ52315048-29F8CCBB-699B-4CC5-A6AB-7D47EDA66794
P2860
Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Immunoglobulin isotypes and fu ...... nd C57BL/6 haemophilia A mice.
@en
Immunoglobulin isotypes and fu ...... nd C57BL/6 haemophilia A mice.
@nl
type
label
Immunoglobulin isotypes and fu ...... nd C57BL/6 haemophilia A mice.
@en
Immunoglobulin isotypes and fu ...... nd C57BL/6 haemophilia A mice.
@nl
prefLabel
Immunoglobulin isotypes and fu ...... nd C57BL/6 haemophilia A mice.
@en
Immunoglobulin isotypes and fu ...... nd C57BL/6 haemophilia A mice.
@nl
P2093
P2860
P921
P1433
P1476
Immunoglobulin isotypes and fu ...... nd C57BL/6 haemophilia A mice.
@en
P2093
D Lillicrap
P2860
P304
P356
10.1111/J.1365-2516.2010.02397.X
P577
2010-11-23T00:00:00Z